Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M Orchard
Observed name:
M. Orchard
OpenAlex ID:
A5109929095
PRS6 EARLY Economic Modelling of a SMART Inhaler Exploring Cost-Effectiveness in a Severe Asthma Setting
2020
·
M. Orchard
, D. Alderson
, et al.
·
Value in Health
·
4
POSB217 Is the Gene Therapy Revolution Sustainable and Affordable?
2022
·
M Orchard
, D Alderson
·
Value in Health
·
1
EE732 From Pipeline to Pricing & Reimbursement: Economic Impact and Access Challenges of Upcoming Gene Therapies
2024
·
E Cooke
, M Orchard
·
Value in Health
HTA257 Consistent Decision-Making by NICE's TSOP Highlights Product Innovation as Critical for HST Routing Success
2024
·
B Mohindru
, M Orchard
, et al.
·
Value in Health
PDF
HTA49 Analysis of Funding Conditions for Orphan Medicines in Spain: Trends in Pricing & Reimbursement
2024
·
M Orchard
·
Value in Health
PDF
HTA127 The Innovative Medicines Fund or the In Need of Medicines Fund: Analysis of NICE Technology Appraisals to Explore Barriers to Managed Access Agreements
2024
·
M Orchard
·
Value in Health
HPR198 By Any Genes Necessary: Review of Pipeline Developments and Access Hurdles Likely to be Faced By Gene Therapies
2023
·
M. Orchard
·
Value in Health
PDF
HTA140 The in Need of Medicines Fund: Analysis of NICE Technology Appraisals to Explore Barriers to Managed Access Via the IMF
2023
·
M. Orchard
, G. Hale
·
Value in Health
PDF
HPR121 By Any Genes Necessary: An Eventful 12 Months in the Gene Therapy Pipeline
2022
·
M Orchard
, J Soboil
·
Value in Health
PDF
POSB252 Highly Specialised Trials: Has Eligibility for NICE Highly Specialised Technology Appraisals Become More Strict?
2022
·
A Child
, M Orchard
·
Value in Health
POSB190 Analysis of the Prevalence of Disease Areas in the Gene Therapy Pipeline: From Ultra-Rare to Prevalent
2022
·
M Orchard
, D Alderson
·
Value in Health
POSB219 A Framework for Gene Therapy Disease Area Targeting
2022
·
M Orchard
, D Alderson
·
Value in Health
PDF
POSB218 Analysis of the Therapy Areas Targeted By Gene Therapy Manufacturers in Clinical Trials
2022
·
M Orchard
, D Alderson
·
Value in Health
PRS63 NON-Adherence in Severe Asthma: Exploration of How to Measure the Extent of IT
2020
·
M. Orchard
, D. Alderson
·
Value in Health
PDF
PNS81 Pricing and Market Access Considerations in Changing from Vial to PRE-Filled Syringe Packaging
2020
·
M. Orchard
, D. Alderson
·
Value in Health
Show more works
View as search
Works count:
15
Citation count:
5
H-index:
1
I10-index:
Year
Topic
Type
